EviCore updates its insurance coverage guidelines to reimburse AI software for analyzing coronary CT angiography (CCTA) images.
Key Details
- 1EviCore now recommends reimbursement for AI-based CCTA analysis from Cleerly, Heartflow, and Elucid.
- 2Guidelines apply to acute or stable chest pain patients and those with noted coronary stenoses.
- 3Policy takes effect October 1, 2024.
- 4Follows Medicare's recent approval and expanded payment for AI-backed CCTA analyses, now covering over 70% of Medicare patients.
- 5CMS doubled hospital/outpatient reimbursement for cardiac CT scans to $357.13 as of January 2024.
Why It Matters
Expanded payer coverage accelerates the clinical adoption of AI-powered CCTA, increasing access and incentives for hospitals to implement these advanced tools, which can aid early detection and personalized treatment for cardiac patients.
Source
Radiology Business
Related News
•AuntMinnie
AI Model Predicts Dosimetry for Lu-177 PSMA Therapy Using PET/CT
A machine learning PET/CT model shows promise for predicting radiation dose prior to Lu-177 PSMA therapy in prostate cancer patients.
•Radiology Business
Navigating Payment and Reimbursement for Radiology AI Solutions
Radiology AI reimbursement in the US remains complex and fragmented, complicating provider and vendor payment strategies.
•HealthExec
Experts Advocate Licensing Model for Clinical AI Regulation
Three prominent medical leaders propose a six-step licensing pathway to govern autonomous clinical AI, drawing direct parallels to physician licensing.